source
- Sensorion halts development of SENS-501 for OTOF-related hearing loss after strategic reviewSensorion announced it is ending the development of its SENS-501 candidate, which was aimed at treating OTOF-related hearing loss, following a strategic review of its pipeline. The biotech said it…
- Biopharma’s top scientists and doctors earned eight-figure pay in 2025, still far below CEO salariesEndpoints News released a compensation report that ranks the ten highest-paid scientists and doctors in biopharma for 2025. The list shows that several executives received eight-figure total compe…